HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67,415 | -5.6% | 1,869 | 0.0% | 0.01% | -18.2% |
| Q1 2023 | $71,377 | -26.3% | 1,869 | +9.8% | 0.01% | -26.7% |
| Q4 2022 | $96,844 | +44.5% | 1,702 | 0.0% | 0.02% | +36.4% |
| Q3 2022 | $67,000 | -10.7% | 1,702 | 0.0% | 0.01% | -8.3% |
| Q2 2022 | $75,000 | +10.3% | 1,702 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $68,000 | -13.9% | 1,702 | -12.9% | 0.01% | -10.0% |
| Q4 2021 | $79,000 | 0.0% | 1,954 | 0.0% | 0.01% | -9.1% |
| Q3 2021 | $79,000 | -11.2% | 1,954 | 0.0% | 0.01% | -8.3% |
| Q2 2021 | $89,000 | +21.9% | 1,954 | +11.3% | 0.01% | +9.1% |
| Q1 2021 | $73,000 | -2.7% | 1,756 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $75,000 | +158.6% | 1,756 | +58.8% | 0.01% | +100.0% |
| Q3 2020 | $29,000 | – | 1,106 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |